Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2025Practice Nursing

Patient education and monitoring of sodium-glucose co-transporter 2 inhibitors in diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMaria Pignatelli-RuizMHMarie Hill

Discussion

Loading...

Member takes

Overview

Evaluation of SGLT2 inhibitors' benefits and local guidelines in T2DM management, indicating the need for enhanced patient education.

Key Points

  • SGLT2 inhibitors improve both cardiovascular and renal health in patients with type 2 diabetes.
  • Local guidelines emphasize patient education and monitoring as crucial for effective SGLT2 inhibitor use.
  • Implementation of nurse-led models is proposed to enhance patient-centered care and safety.
  • Monitoring side effects is essential to support safe prescribing and effective management.

Cite This Study

Pignatelli-Ruiz et al. (2025) studied this question.

synapsesocial.com/papers/68de5da283cbc991d0a206e2https://doi.org/10.12968/pnur.2025.0043
View Full Paper
Ask AI
Bookmark
Share